eprintid: 20980
rev_number: 8
eprint_status: archive
userid: 3858
dir: disk0/00/02/09/80
datestamp: 2023-02-13 03:35:31
lastmod: 2023-02-13 03:35:31
status_changed: 2023-02-13 03:35:31
type: thesis
metadata_visibility: show
creators_name: Nugrahaningrum, Karina
creators_name: Rusdi, Numlil Khaira
creators_name: Wulandari, Nora
title: EFEKTIVITAS PENGGUNAAN ANTIBIOTIK PADA PASIEN ULKUS
DIABETIKUM DI RUMAH SAKIT PUSAT ANGKATAN DARAT
GATOT SOEBROTO JAKARTA TAHUN 2018
ispublished: pub
subjects: R
subjects: RS
divisions: 48201
abstract: Diabetes adalah sekelompok penyakit metabolik yang ditandai oleh hiperglikemia
yang dihasilkan dari cacat sekresi insulin, aksi insulin, atau keduanya. Komplikasi
kronis diabetes misalnya berupa neuropati (kerusakan syaraf) di kaki yang
meningkatkan kejadian ulkus kaki, infeksi dan bahkan keharusan untuk amputasi
kaki. Terapi antibiotik diperlukan untuk hampir semua luka kaki diabetes yang
terinfeksi. Penelitian ini bertujuan untuk mengetahui gambaran penggunaan terapi
antibiotik empiris dan definitif serta efektivitasnya berdasarkan nilai leukosit.
Data diperoleh dengan metode retrospektif dari rekam medik pasien yang
termasuk dalam syarat inklusi selama tahun 2018. Toolkit yang digunakan adalah
IDSA tahun 2012 dan Antibiogram RSPAD tahun 2017. Jumlah sampel dalam
penelitian ini adalah 59 pasien. Hasil yang diperoleh menunjukkan bahwa
sebanyak 95,38% kasus dari terapi empiris dan 100% kasus dari terapi definitif
menggunakan antibiotik yang sesuai dengan literatur. 63,08% kasus dari terapi
empiris dan 96,67% kasus dari terapi definitif yang sesuai mengalami penurunan
leukosit dan perbaikan kondisi pasien.
Kata kunci: Ulkus Diabetikum, Antibiotik, Efektivitas.
date: 2021
date_type: completed
full_text_status: public
institution: Universitas Muhammadiyah Prof. DR. HAMKA
department: Fakultas Farmasi dan Sains
thesis_type: bachelor
thesis_name: bphil
referencetext: Abbas, M., Uçkay, I., & Lipsky, B. A. (2015). In diabetic foot infections
antibiotics are to treat infection, not to heal wounds. Expert Opinion on
Pharmacotherapy, 16(6), 821–832.
Abdel Wahab, W. F. (2014). Diabetic Foot Infections with Pseudomonas: Jabir
Abueliz Diabetic Center Khartoum Experience. Clinical Research on Foot
& Ankle, s3(01), 1.
Al-Rubeaan, K., Al Derwish, M., Ouizi, S., Youssef, A. M., Subhani, S. N.,
Ibrahim, H. M., & Alamri, B. N. (2015). Diabetic foot complications and
their risk factors from a large retrospective cohort study. PloS one, 10(5),
e0124446.
Alavi, A., Bader, M. S., & Sibbald, R. G. (2014). Management of Diabetic Foot
Infections with Appropriate Use of Antimicrobial Therapy. Clin Res Foot
Ankle, 3, 10.
Albert, S. (2002). Cost-effective management of recalcitrant diabetic foot ulcers.
In Clinics in Podiatric Medicine and Surgery (Vol. 19, Issue 4, pp. 483–
491).
Care, D., & Suppl, S. S. (2018a). 2. Classification and Diagnosis of Diabetes:
Standards of Medical Care in Diabetes—2018. Diabetes Care,
41(Supplement 1), S13–S27.
Care, D., & Suppl, S. S. (2018b). 2. Classification and Diagnosis of Diabetes:
Standards of Medical Care in Diabetes—2018. Diabetes Care,
41(Supplement 1), S13–S27.
Charles & Anne. (2015). Bersahabat dengan Diabetes Mellitus Tipe 2. Penebar
Plus.
Citron, D. M., Goldstein, E. J. C., Merriam, C. V., Lipsky, B. A., & Abramson,
M. A. (2007). Bacteriology of moderate-to-severe diabetic foot infections
and in vitro activity of antimicrobial agents. Journal of Clinical
Microbiology, 45(9), 2819–2828.
Clay, P. G., Graham, M. R., Lindsey, C. C., Lamp, K. C., Freeman, C., & Glaros,
A. (2004). Clinical efficacy, tolerability, and cost savings associated with
the use of open-label metronidazole plus ceftriaxone once daily compared
with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic
lower-extremity infections in older mal. American Journal Geriatric
Pharmacotherapy, 2(3), 181–189. 
Cyriac, J. M., & James, E. (2014). Switch over from intravenous to oral therapy:
A concise overview. In Journal of Pharmacology and
Pharmacotherapeutics (Vol. 5, Issue 2, pp. 83–87). J Pharm acol
Pharmacother.
Decroli, E., Karimi, J., Manaf, A., & Syahbuddin, S. (2008). Profil Ulkus
Diabetik pada Penderita Rawat Inap di Bagian Penyakit Dalam RSUP Dr
M. Djamil Padang. Majalah Kedokteran Indonesia, 3–7.
Dipiro, C., Wells, B., Schwinghammer, T., & DiPiro, J. (2014). Pharmacotherapy
Handbook, 9 Edition. 7, 976.
Dunyach-Remy, C., Essebe, C. N., Sotto, A., & Lavigne, J. P. (2016).
Staphylococcus aureus toxins and diabetic foot ulcers: Role in
pathogenesis and interest in diagnosis. Toxins, 8(7), 1–20.
Ebner, P., Rinker, J., Nguyen, M. T., Popella, P., Nega, M., Luqman, A., Schittek,
B., Di Marco, M., Stevanovic, S., & Götza, F. (2016). Excreted
cytoplasmic proteins contribute to pathogenicity in Staphylococcus aureus.
Infection and Immunity, 84(6), 1672–1681.
Edmonds, M. (2009). The treatment of diabetic foot infections: Focus on
ertapenem. Vascular Health and Risk Management, 5, 949–963.
Fortuna, S. (2016). SKRIPSI STUDI PENGGUNAAN ANTIBIOTIKA PADA
PASIEN DIABETES MELITUS.
Gde, T., Pemayun, D., & Naibaho, R. M. (2016). Diabetic Foot Ulcer Registry at
a Tertiary Care Hospital in Semarang , Indonesia : an Overview of its
Clinical Profile and Management Outcome. Diabetes Management, 6(4),
82–89.
Gómez-Arámbula, H., Hidalgo-Hurtado, A., Rodríguez-Flores, R., GonzálezAmaro, A. M., Garrocho-Rangel, A., & Pozos-Guillén, A. (2015).
Moxifloxacin versus Clindamycin/Ceftriaxone in the management of
odontogenic maxillofacial infectious processes: A preliminary,
intrahospital, controlled clinical trial. Journal of Clinical and
Experimental Dentistry, 7(5), e634–e639.
Hauser, A. R. (2018). Antibiotic basics for clinicians: The ABCs of choosing the
right antibacterial agent. In Antibiotic Basics for Clinicians: The ABCs of
Choosing the Right Antibacterial Agent.
Ibrahim, A., Jude, E., Langton, K., Martinez-De Jesus, F., Harkless, L., Gawish,
H., Huang, Y.-Y., Labovitz, J., XU, Z., Pendsey, S., LIU, F., Sadikot, S.,
& Han Cho, N. (2017). IDF Clinical Practice Recommendations on the
Diabetic Foot – 2017. A guideline for healthcare professionals. In 
International Diabetes Federation.
Isnaini, N., & Ratnasari, R. (2018). Faktor risiko mempengaruhi kejadian
Diabetes mellitus tipe dua. Jurnal Kebidanan Dan Keperawatan Aisyiyah,
14(1), 5968.
Jeffcoate, W., & Harding, K. (2005). Diabetic foot ulcers. The Lancet, 7424.
Kartika, R. W. (2017). Pengelolaan gangren kaki Diabetik. Continuing Medical
Education, 44(1), 18–22.
Kemenkes RI. (2014). Situasi dan Analisis Diabetes. In Pusat Data dan Informasi
Kementerian Kesehatan RI (p. 2).
Keskek, S. O., Kirim, S., & Yanmaz, N. (2014). Estimated costs of the treatment
of diabetic foot ulcers in a tertiary hospital in Turkey. Pakistan Journal of
Medical Sciences, 30(5).
Khalique, S. (2014). Evaluation of the Effect of Inadaptable Risk Factors & Social
Status on Diabetic Foot Ulcer. INTERNATIONAL JOURNAL OF
ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR), 2(2), 78.
Kurniawan, L. B., Ensa, T., & Sennang, N. (2011). Aerob Microbes Pattern and
Antimicrobial Sensitivity of Diabetic Foot Ulcer. Indonesian Journal of
Clinical Pathology and Medical Laboratory, 18(1), 1–3.
Leekha, S., Terrell, C. L., & Edson, R. S. (2011). General principles of
antimicrobial therapy. Mayo Clinic Proceedings, 86(2), 156–167.
Lipsky, B. A., et al., (2012a). 2012 infectious diseases society of America clinical
practice guideline for the diagnosis and treatment of diabetic foot
infections. Clinical Infectious Diseases, 54(12), 132–173.
Lipsky, B. A., et al. (2012b). 2012 infectious diseases society of America clinical
practice guideline for the diagnosis and treatment of diabetic foot
infections. In Clinical Infectious Diseases (Vol. 54, Issue 12). Clin Infect
Dis. https://doi.org/10.1093/cid/cis346
Löfmark, S., Edlund, C., & Nord, C. E. (2010). Metronidazole Is Still the Drug of
Choice for Treatment of Anaerobic Infections. Clinical Infectious
Diseases, 50(Supplement_1), S16–S23.
Muslim, Z., Novrianti, A., & Irnameria, D. (2020). Resistance Test Of Bacterial
Causes Of Urinary Tract Infection Against Ciprofloxacin And Ceftriaxone
Antibiotics. SANITAS: Jurnal Teknologi Dan Seni Kesehatan, 11(2), 203–
212.
Nur, A., & Marissa, N. (2016). Gambaran Bakteri Ulkus Diabetikum di Rumah 
Sakit Zainal Abidin dan Meuraxa Tahun 2015. Buletin Penelitian
Kesehatan, 44(3).
Scott, G. (2013). The diabetic foot examination: A positive step in the prevention
of diabetic foot ulcers and amputation. In Osteopathic Family Physician
(Vol. 5, Issue 2, pp. 73–78). No longer published by Elsevier.
Setiawan, E., Felix, H., & Setiadi, A. P. (2017). Analysis of the utilization and
cost of antibiotics at an intensive care unit in Surabaya. Pharmaciana,
7(2), 217.
Smith-Strøm, H., Iversen, M. M., Graue, M., Skeie, S., & Kirkevold, M. (2016).
An integrated wound-care pathway, supported by telemedicine, and
competent wound management—Essential in follow-up care of adults with
diabetic foot ulcers. International Journal of Medical Informatics, 94, 59–
66.
Talan, D. A., Summanen, P. H., & Finegold, S. M. (2000). Ampicillin/sulbactam
and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses
in patients with or without histories of injection drug abuse. Clinical
Infectious Diseases, 31(2), 464–471.
Wolcott, R. (2015). Economic aspects of biofilm-based wound care in diabetic
foot ulcers. Journal of Wound Care, 24(5), 189–194.
Yao, M., Hasturk, H., Kantarci, A., Gu, G., Garcia-Lavin, S., Fabbi, M., Park, N.,
Hayashi, H., Attala, K., French, M. A., & Driver, V. R. (2014). A pilot
study evaluating non-contact low-frequency ultrasound and underlying
molecular mechanism on diabetic foot ulcers. International Wound
Journal, 11(6), 586–593.
Yotsu, R. R., Pham, N. M., Oe, M., Nagase, T., Sanada, H., Hara, H., Fukuda, S.,
Fujitani, J., Yamamoto-Honda, R., Kajio, H., Noda, M., & Tamaki, T.
(2014). Comparison of characteristics and healing course of diabetic foot
ulcers by etiological classification: Neuropathic, ischemic, and neuroischemic type. Journal of Diabetes and Its Complications, 28(4), 528–535.
Zhang, P., Lu, J., Jing, Y., Tang, S., Zhu, D., & Bi, Y. (2017). Global
epidemiology of diabetic foot ulceration: a systematic review and metaanalysis†. In Annals of Medicine (Vol. 49, Issue 2, pp. 106–116).
citation:   Nugrahaningrum, Karina dan Rusdi, Numlil Khaira dan Wulandari, Nora  (2021) EFEKTIVITAS PENGGUNAAN ANTIBIOTIK PADA PASIEN ULKUS DIABETIKUM DI RUMAH SAKIT PUSAT ANGKATAN DARAT GATOT SOEBROTO JAKARTA TAHUN 2018.  Bachelor thesis, Universitas Muhammadiyah Prof. DR. HAMKA.   
document_url: http://repository.uhamka.ac.id/id/eprint/20980/1/FS03-210286.pdf